Archimedes for biopsy of suspected lung cancerStatus:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Signatera molecular residual disease assay (MT741)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC